By Andy Choi
A report on ‘Minimally Invasive Surgical Instruments, Imaging & Visualization Systems and Medical Robotics Market (2011 - 2016)’ evaluates and examines the major market restraints, drivers, and opportunities in Europe, Asia, across America and worldwide.
Minimally invasive surgical (MIS) procedure is conducted with small incisions in the body, which is effective for treating plaque blockages within the arteries of heart and vessel walls of peripheral organs such as brain, lower extremities, neck, and kidneys. These procedures are effective than other surgeries such as low risk of infection, less bleeding, short recovery time and hospital stays as well as minimal scars.
The market for global minimally invasive surgical devices has been divided into inflation systems, handheld instruments, auxiliary devices, CT & MRI imaging, guiding devices, ultrasound, X-ray, robotic-assisted surgery systems and electrosurgical devices. MIS market will rapidly increase at CAGR rate of 8.2% between 2011 and 2016.
The global minimally invasive surgical market has witnessed powerful and promising environments representing $23 B in 2011 with an estimated annual growth rate of 8% till 2016. Medical devices based on several technological innovations have been familiar during the past years. New devices with safety and efficiency capabilities emerge giving rise to minimally invasive procedures that can be used by global surgeons. Despite the low investment in R&D for MIS, the overall revival will be affected by venture funding owing to the slow improvement of economic conditions.
Multinationals including Covidien, GE Healthcare, Philips, Siemens and Intuitive Surgical contribute to the global market for minimally invasive surgery devices and imaging & visualization systems.